Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Hematologic Neoplasms × Dasatinib × Clear all

Sponsor

Conditions

Leukemia, Myelogenous, Chronic, BCR-ABL Positive 14 Breast Neoplasms 13 Precursor Cell Lymphoblastic Leukemia-Lymphoma 12 Leukemia 11 Leukemia, Myeloid, Chronic-Phase 10 Prostatic Neoplasms 8 Recurrence 6 Lung Neoplasms 6 Leukemia, Lymphocytic, Chronic, B-Cell 6 Carcinoma, Non-Small-Cell Lung 6 Neoplasm Metastasis 5 Burkitt Lymphoma 5 Melanoma 4 Glioblastoma 4 Squamous Cell Carcinoma of Head and Neck 3 Pancreatic Neoplasms 3 Ovarian Neoplasms 3 Neoplasms 3 Leukemia, Myeloid, Acute 3 Gliosarcoma 3 Blast Crisis 3 Sarcoma 2 Salivary Gland Neoplasms 2 Rhabdomyosarcoma 2 Rectal Neoplasms 2 Polycythemia Vera 2 Oligodendroglioma 2 Multiple Myeloma 2 Lymphoma 2 Leukemia, Myelomonocytic, Chronic 2

Interventions

Cyclophosphamide 31 fludarabine 23 fludarabine phosphate 22 Tacrolimus 22 Whole-Body Irradiation 21 Mycophenolic Acid 19 Busulfan 14 Melphalan 11 thymoglobulin 10 Methotrexate 10 Granulocyte Colony-Stimulating Factor 10 Antilymphocyte Serum 10 Stem Cell Transplantation 9 Rituximab 9 Filgrastim 8 Thiotepa 7 Cyclosporine 7 Radiotherapy 6 Peripheral Blood Stem Cell Transplantation 6 Mesna 6 Cytarabine 6 Nivolumab 5 Bortezomib 5 Alemtuzumab 5 trametinib 4 Sirolimus 4 Hematopoietic Stem Cell Transplantation 4 Dexamethasone 4 Cyclosporins 4 venetoclax 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡